ArticlePloS one2026
A simplified two-dimensional culture system supports meiotic progression during mouse spermatogenesis in vitro.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In vitro spermatogenesis (IVS) remains a major challenge due to its complexity and extended duration. Although organ culture of neonatal mouse testes can support complete spermatogenesis, its three-dimensional structure limits precise observation and control of culture conditions, resulting in heterogeneous oxygen and nutrient gradients. Two-dimensional (2-D) systems provide greater accessibility but often induce accelerated or abnormal meiosis. In this study, we present a simplified, serum free 2-D culture system that enables meiotic progression of mouse germ cells to the mid pachytene stage. Testicular cells from Acrosin (Acr)-GFP transgenic mice (2.5 to 10.5 days postpartum: dpp) were enzymatically dissociated and cultured in APEL medium, a chemically defined and serum free basal formulation. The medium was supplemented with bovine pituitary extract (BPE), follicle stimulating hormone (FSH), and testosterone (BFT medium). Meiotic progression was monitored in real time by GFP fluorescence and further assessed by immunocytochemistry and nuclear spread analysis. Testicular cells consistently formed Sertoli cell monolayers and supported germ cell differentiation to mid pachytene stage. GFP-positive cells appeared around days 17.5 to 21.5 of culture, reflecting a modest delay compared to organ culture. GFP-positive cells were observed not only in 7.5 to 10.5 dpp cultures, but also in 2.5 to 6.5 dpp testes lacking preexisting spermatocytes, indicating de novo induction of meiosis. BFT medium, compared to APEL medium, increased the frequency of GFP-positive wells and the per-well duration of GFP expression, reaching statistical significance in the 9.5-10.5 dpp group (p = 0.021). Nuclear spread analysis confirmed synapsis through pachytene, although cells did not progress to diplotene. This simplified culture system offers a robust and accessible platform for studying early meiotic events and optimizing IVS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.